Discontinuation report EES-200
Report ID | 13646 |
Drug Identification Number | 00000299 |
Brand name | EES-200 |
Common or Proper name | erythromycin ethylsuccinate oral suspension USP |
Company Name | AMDIPHARM LIMITED |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | ERYTHROMYCIN |
Strength(s) | 40MG |
Dosage form(s) | POWDER FOR SUSPENSION |
Route of administration | ORAL |
Packaging size | All |
ATC code | J01FA |
ATC description | MACROLIDES, LINCOSAMIDES AND STREPTOGRAMINS |
Reason for discontinuation | Business reasons |
Anticipated discontinuation date | 2017-06-21 |
Actual discontinuation date | 2017-06-21 |
Remaining supply date | 2017-06-21 |
Discontinuation status | Discontinued |
Discontinuation decision reversal | No |
Information on remaining supply | |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 3 BURLINGTON ROAD DUBLIN, LEINSTER IRELAND DUBLIN 4 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v2 | 2017-06-22 | French | Compare |
v1 | 2017-06-22 | English | Compare |
Showing 1 to 2 of 2